arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Ruchi Roy

2 papers · 2015–2023

2015: 12016: 02017: 02018: 02019: 02020: 02021: 02022: 02023: 1
2015peak 1 in 20152023

Frequent co-authors

Papers

showing 1–2 of 2 RSS

Racial and gendered experiences that dissuade a career in the professoriate

William H. Robinson, Ebony O. McGee, Lydia Bentley +3 more

Safety Research · · cited 11× · DOI ↗ · more like this ·

Faculty members play a multi-faceted role in the engineering profession. They help to discover, promote, and disseminate advancements in technology, and they engage in capacity-building by training a future workforce of engineers. Yet, many potential faculty members are dissuaded from academia. This paper describes findings from both interviews and focus groups of 60 Black engineering Ph.D. students and postdoctoral scholars, which were conducted during our study to understand their career decision-making process. Their racial and gendered experiences impact their desire and choice to pursue an academic career.

Challenges and the Advancement in High-Throughput Screening Strategies for Cancer Therapeutics

Ruchi Roy, Sunil Kumar Singh, Sweta Misra

Computational Theory and Mathematics · Preprints.org · · cited 0× · DOI ↗ · more like this ·

Drug discovery utilizes high-throughput screening (HTS) methods applying target and cell-based assays. This review discusses the challenges and benefits associated with these assays in HTS. Discussed the strategies that can be applied for the development of screening assays through primary and secondary screens for target identification. Further discussion on identify-ing the most efficacious drugs following these approaches in cancer. Even though various drugs have been identified to treat cancer, there is high demand of more relevant phenotypic assays to produce desired diseased phenotype to only highlighting the specific targets instead of off-targets. Hopefully, the new developing strategies could provide innovative drugs to treat cancer patients to reduce mortality rate.